The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Robbins and Cotran Pathologic Basis of Disease
Hoda, S. A., & Hoda, R. S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa163 · Cited by 3,365
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Hanks, S. K., & Hunter, T. R. (1995) · PubMed · Cited by 2,518
The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1
Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,318
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Harrison’s Principles of Internal Medicine
Malani, P. N. (2012) · JAMA · doi:10.1001/jama.308.17.1813-b · Cited by 2,039
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050540c · Cited by 2,031
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862342 · Cited by 1,759
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Self-citationSignal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,608
Cohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,554
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Self-citationTumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
Protein Tyrosine Kinase Structure and Function
Hubbard, S. R., & Till, J. H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.373 · Cited by 1,171
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
SIGNALLING BY RECEPTOR TYROSINE KINASES
Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002321 · Cited by 1,086
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., & Sato, M. (1990) · PubMed · Cited by 960
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862343 · Cited by 960
Protein kinases: evolution of dynamic regulatory proteins
Taylor, S. S., & Kornev, A. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.09.006 · Cited by 945
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
Self-citationFolkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D. E., & Vlodavsky, I. (1988) · PubMed Central · Cited by 875
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
Kornev, A. P., Haste, N. M., Taylor, S. S., & Ten Eyck, L. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607656103 · Cited by 762
Jonasch, E., Gao, J., & Rathmell, W. K. (2014) · BMJ · doi:10.1136/bmj.g4797 · Cited by 636
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.01.003 · Cited by 607
Self-citationVascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
Self-citationMcTigue, M., Murray, B. W., Chen, J. H., Deng, Y.-L., Solowiej, J., & Kania, R. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207759109 · Cited by 592
Resistance to targeted therapy in renal-cell carcinoma
Rini, B. I., & Atkins, M. B. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70240-2 · Cited by 569
A historical overview of protein kinases and their targeted small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.010 · Cited by 526
Self-citationThrough the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
Zuccotto, F., Ardini, E., Casale, E., & Angiolini, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901443h · Cited by 518
Liao, J. J.-L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0608107 · Cited by 507
Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., & Lemischka, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9026 · Cited by 501
Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor
Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., Wells, J. A., & de Vos, A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80456-0 · Cited by 486
A helix scaffold for the assembly of active protein kinases
Kornev, A. P., Taylor, S. S., & Ten Eyck, L. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807988105 · Cited by 442
Clark, D. E., Smith, S. K., He, Y., Day, K. A., Licence, D. R., Corps, A. N., Lammoglia, R., & Charnock-Jones, D. S. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.6.1540 · Cited by 414
Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Roskoski, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.156 · Cited by 412
Self-citationOgawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 406
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.038 · Cited by 373
Self-citationTie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
EKLUND, L., & OLSEN, B. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.09.002 · Cited by 343
Lymphatic System in Cardiovascular Medicine
Aspelund, A., Robciuc, M. R., Karaman, S., Makinen, T., & Alitalo, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306544 · Cited by 321
Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
Roskoski, R. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.11.007 · Cited by 303
Self-citationKLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space
van Linden, O. P. J., Kooistra, A. J., Leurs, R., de Esch, I. J. P., & de Graaf, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400378w · Cited by 298
Winer, E., Gralow, J., Diller, L., Karlan, B., Loehrer, P., Pierce, L., Demetri, G., Ganz, P., Kramer, B., Kris, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2134 · Cited by 293
Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.
Okamoto, K., Ikemori-Kawada, M., Jestel, A., von König, K., Funahashi, Y., Matsushima, T., Tsuruoka, A., Inoue, A., & Matsui, J. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500394m · Cited by 285
Vascular Endothelial Growth Factor Localization in the Adult
Maharaj, A. S. R., Saint-Geniez, M., Maldonado, A. E., & D'Amore, P. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050834 · Cited by 281
VEGF receptor protein–tyrosine kinases: Structure and regulation
Roskoski, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.121 · Cited by 269
Self-citationMuller, Y. A., Chen, Y., Christinger, H. W., Li, B., Cunningham, B. C., Lowman, H. B., & de Vos, A. M. (1998) · Structure · doi:10.1016/s0969-2126(98)00116-6 · Cited by 264
Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
Ahmad, T., & Eisen, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-040028 · Cited by 244
Muller, Y. A., Christinger, H. W., Keyt, B. A., & de Vos, A. M. (1997) · Structure · doi:10.1016/s0969-2126(97)00284-0 · Cited by 237
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.012 · Cited by 237
Self-citationEbos, J. M. L., Bocci, G., Man, S., Thorpe, P. E., Hicklin, D. J., Zhou, D., Jia, X., & Kerbel, R. S. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.315.2.6 · Cited by 211
Deciphering the Structural Basis of Eukaryotic Protein Kinase Regulation
Meharena, H. S., Chang, P., Keshwani, M. M., Oruganty, K., Nene, A. K., Kannan, N., Taylor, S. S., & Kornev, A. P. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001680 · Cited by 208
Pazopanib: A novel multitargeted tyrosine kinase inhibitor
Sonpavde, G., & Hutson, T. E. (2007) · Current Oncology Reports · doi:10.1007/s11912-007-0007-2 · Cited by 203
Neuropilin Functions as an Essential Cell Surface Receptor
Guo, H.-F., & Vander Kooi, C. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.687327 · Cited by 200
Structural determinants of growth factor binding and specificity by VEGF receptor 2
Leppänen, V.-M., Prota, A. E., Jeltsch, M., Anisimov, A., Kalkkinen, N., Strandin, T., Lankinen, H., Goldman, A., Ballmer-Hofer, K., & Alitalo, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914318107 · Cited by 177
Vascular Endothelial Growth Factor-B in Physiology and Disease
Bry, M., Kivelä, R., Leppänen, V.-M., & Alitalo, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00028.2013 · Cited by 173
Salameh, A., Galvagni, F., Bardelli, M., Bussolino, F., & Oliviero, S. (2005) · Blood · doi:10.1182/blood-2005-04-1388 · Cited by 173
Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression
HEROULT, M., SCHAFFNER, F., & AUGUSTIN, H. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.028 · Cited by 160
VEGFR-2 conformational switch in response to ligand binding
Sarabipour, S., Ballmer‐Hofer, K., & Hristova, K. A. (2016) · eLife · doi:10.7554/elife.13876 · Cited by 147
Wei, L., Hubbard, S. R., Hendrickson, W. A., & Ellis, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8122 · Cited by 136
Kendall, R. L., Rutledge, R. Z., Mao, X., Tebben, A. J., Hungate, R. W., & Thomas, K. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6453 · Cited by 136
Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD
Bui, H. M., Enis, D. R., Robciuc, M. R., Nurmi, H. J., Cohen, J. D., Chen, M., Yang, Y., Dhillon, V., Johnson, K., Zhang, H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83967 · Cited by 135
Robinson, C., Johnson, D., Chang, E., Armstrong, D. M., & Wang, W. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.12.049 · Cited by 126
Crystal Structures of Novel Vascular Endothelial Growth Factors (VEGF) from Snake Venoms
Suto, K., Yamazaki, Y., Morita, T., & Mizuno, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411395200 · Cited by 121
Roskoski, R. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.009 · Cited by 119
Self-citationEbos, J. M. L., Lee, C. R., Bogdanovic, E., Alami, J., Slyke, P. V., Francia, G., Xu, P., Mutsaers, A. J., Dumont, D., & Kerbel, R. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3217 · Cited by 115
Guidelines for preparing color figures for everyone including the colorblind
Roskoski, R. J. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.005 · Cited by 112
Self-citationIyer, S., Leonidas, D. D., Swaminathan, G. J., Maglione, D., Battisti, M., Tucci, M., Persico, M. G., & Acharya, K. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008055200 · Cited by 110
New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
Zarrabi, K. K., Fang, C.-H., & Wu, S. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0374-y · Cited by 102
Structural determinants of vascular endothelial growth factor-D receptor binding and specificity
Leppänen, V., Jeltsch, M., Anisimov, A., Tvorogov, D., Aho, K., Kalkkinen, N., Toivanen, P. I., Ylä‐Herttuala, S., Ballmer‐Hofer, K., & Alitalo, K. K. (2010) · Blood · doi:10.1182/blood-2010-08-301549 · Cited by 94
Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms
Roskoski, R. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.011 · Cited by 94
Self-citationLagercrantz, J., Farnebo, F. A., Larsson, C., Tvrdik, T., Weber, G., & Piehl, F. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00040-2 · Cited by 92
Zhang, Y., Guessous, F., Kofman, A., Schiff, D., & Abounader, R. (2010) · PubMed · Cited by 88
Galvagni, F., Pennacchini, S., Salameh, A., Rocchigiani, M., Neri, F., Orlandini, M., Petraglia, F., Gotta, S., Sardone, G. L., Matteucci, G., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206326 · Cited by 87
Meyer, R., Mohammadi, M., & Rahimi, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506454200 · Cited by 86
Approved and Experimental Small‐Molecule Oncology Kinase Inhibitor Drugs: A Mid‐2016 Overview
Fischer, P. M. (2016) · Medicinal Research Reviews · doi:10.1002/med.21409 · Cited by 84
Hansen, C. R., Grimm, D. G., Bauer, J. W., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020461 · Cited by 84
Hussein, Z., Mizuo, H., Hayato, S., Namiki, M., & Shumaker, R. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0403-4 · Cited by 72
VEGF Receptor Tyrosine Kinases
Álvarez-Aznar, A., Muhl, L., & Gaengel, K. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.001 · Cited by 66
Solowiej, J. E., Bergqvist, S., McTigue, M. A., Marrone, T. J., Quenzer, T. L., Cobbs, M., Ryan, K., Kania, R. S., Diehl, W. C., & Murray, B. W. (2009) · Biochemistry · doi:10.1021/bi900522y · Cited by 52
Iyer, S., Scotney, P. D., Nash, A. D., & Acharya, K. R. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.002 · Cited by 47
Muhl, L., Moessinger, C., Adzemovic, M. Z., Dijkstra, M. H., Nilsson, I., Zeitelhofer, M., Hagberg, C. E., Huusko, J., Falkevall, A., Ylä‐Herttuala, S., et al. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2377-y · Cited by 43
Blood vessels as targets in tumor therapy
Claesson, L. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.660550 · Cited by 41
Jeltsch, M., Kärpänen, T., Strandin, T. M., Aho, K., Lankinen, H., & Alitalo, K. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511593200 · Cited by 40
Roskoski, R. J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.813015 · Cited by 39
Self-citationKIDs rule: regulatory phosphorylation of RTKs
Locascio, L. E., & Donoghue, D. J. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.12.001 · Cited by 33
Manni, S., Kisko, K., Schleier, T., Missimer, J., & Ballmer‐Hofer, K. (2014) · The FASEB Journal · doi:10.1096/fj.14-256206 · Cited by 19
Cited by
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Roskoski, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104609 · Cited by 559
Self-citationProperties of FDA-approved small molecule protein kinase inhibitors
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.006 · Cited by 554
Self-citationRoskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.014 · Cited by 487
Self-citationCyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.035 · Cited by 393
Self-citationProperties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Roskoski, R. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107059 · Cited by 383
Self-citation
Metadata
- Authors
- Roskoski, R.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 120
- Pages
- 116-132
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2601673178
- Cited by
- 260
- References
- 109
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.